Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer
- 1Departament of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Hospital del Mar Research Institute, Barcelona, Spain.
- 2Hospital del Mar Research Institute, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
- 3Hospital del Mar Research Institute, Barcelona, Spain.
- 4Department of Pathology, Hospital del Mar, Barcelona, Spain.
- 5Hospital del Mar Research Institute, Barcelona, Spain; Department of Pathology, Hospital del Mar, Barcelona, Spain.
- 6Hospital del Mar Research Institute, Barcelona, Spain; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.
- 7Hospital del Mar Research Institute, Barcelona, Spain; Department of Urology, Hospital del Mar, Barcelona, Spain.
- 8Departament of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Department of Pathology, Hospital del Mar, Barcelona, Spain.
- 0Departament of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Hospital del Mar Research Institute, Barcelona, Spain.
|
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Loss of PARP1 and gain of PARP2 are common in prostate cancer (PCa) and linked to aggressive disease. PARP2 alterations significantly impact prognosis, suggesting copy number analysis can predict PCa outcomes.
Area Of Science
- Oncology
- Genetics
- Molecular Biology
Background
- Poly (ADP-ribose) polymerase 1/2 (PARP1/2) play roles in DNA repair and androgen receptor regulation.
- PARP1/2 protein overexpression is linked to resistance to androgen deprivation therapy and prostate cancer (PCa) progression.
- The prognostic significance of PARP1/2 genomic alterations in PCa remains understudied.
Purpose Of The Study
- To investigate PARP1/2 copy number alterations in PCa.
- To assess the prognostic value of these alterations.
- To explore their potential for therapeutic stratification.
Main Methods
- Real-time PCR was used to evaluate PARP1/2 copy number status in 121 primary PCa tumors.
- BRCA1/2 somatic mutations were analyzed in 24 PCa cases.
- Associations with clinicopathological features, metastasis, and PSA recurrence were assessed.
Main Results
- PARP1 loss (34.7%) and PARP2 gain (32.2%) were frequent and co-occurred significantly (P < .001).
- Both alterations correlated with locally advanced disease, metastasis, and aggressive features (Gleason pattern 5, high-grade/stage).
- Exclusive PARP2 gain was associated with the shortest time to PSA recurrence; wild-type patients had the best outcomes (P = .007).
Conclusions
- PARP1 loss and PARP2 gain are common, co-occurring alterations associated with PCa aggressiveness.
- PARP2 alterations significantly impact disease prognosis.
- PARP1/2 copy number analysis may aid in predicting PCa outcomes and warrants further therapeutic evaluation.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:26
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

